ORIC

ORIC R&D Expenses

$122.36MTTM · USD

Period ending:

ORIC FY R&D ExpensesUSD
ORIC FY R&D Expenses2017-12-31: $19.13M2018-12-31: $19.03M2019-12-31: $22.84M2020-12-31: $60.76M2021-12-31: $56.86M2022-12-31: $61.68M2023-12-31: $85.17M2024-12-31: $114.07M2025-12-31: $109.82M$114.07M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ORIC r&d expenses history

Research and development spending. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Oric Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
109,818,000
114,072,000
85,172,000
61,680,000
56,858,000
60,764,000
22,844,000
19,026,000
19,126,000

Compare r&d expenses

All ORIC financial metrics · ORIC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.